Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity
Christopher J. Winrow(Merck & Co., Inc., Rahway, NJ, USA (United States)), Carrolee Barlow(Escape Therapeutics (United States))
Cited by 176
Related Papers
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
|New England Journal of Medicine|2016|555
Alteration of Gene Expression by Chromosome Loss in the Postnatal Mouse Brain
|Journal of Neuroscience|2003|113